0.2580
+0.0120
+(4.88%)
At close: April 17 at 4:00:01 PM EDT
0.2412
-0.02
(-6.51%)
After hours: April 17 at 6:15:50 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jin Wook Suk | CEO & Chairman of the Board | -- | -- | 1979 |
| Mr. Eugene Y. Chan M.D. | Co-Founder | 250k | -- | 1975 |
| Dr. Robert J. Markelewicz Jr., M.D. | Chief Medical Officer | 466.12k | -- | 1980 |
Abpro Holdings, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Abpro Holdings, Inc., a biotechnology company, provides antibody therapeutics for cancer related issues. Its platform DiversImmune addresses the antibody therapeutics. The company's product candidates include ABP-102 for the treatment of breast and gastric cancer; and ABP-110 for the treatment of liver cancer. It also offers ABP-105 for the treatment of gastric cancer and ABP 201 for vascular diseases of the eye and diabetic macular edema. Abpro Holdings, Inc. was incorporated in 2004 and is based in Woburn, Massachusetts.
Corporate Governance
Abpro Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
W2J.F Carisma Therapeutics, Inc.
0.1708
-2.68%
OCTHF Oxford Cannabinoid Technologies Holdings Plc
0.0028
0.00%
PBM Psyence Biomedical Ltd.
0.4381
-5.74%
G28.F Tevogen Bio Holdings Inc.
0.8800
-1.79%
0TB.F Theravance Biopharma, Inc.
7.50
+0.67%
FNAM Evolutionary Genomics, Inc.
0.0002
0.00%
W2J.MU CARISMA Therapeutics Inc
0.1756
+1.86%
8EM.SG Editas Medicine Inc
1.1140
+2.63%
RDTCF Rapid Dose Therapeutics Corp.
0.1393
0.00%
WSNAF Wesana Health Holdings Inc.
0.0206
0.00%